February 24, 2021
1 min read

Lanka may junk Sinopharm, orders 13.5 Mn vax from India

Sri Lanka has ordered 13.5 million Oxford AstraZeneca coronavirus vaccines in addition to the 500,000 doses gifted by India, and the country may not use Chinese vaccines in the second phase of immunisation, a government spokesman has said.

Ramesh Pathirana, who is also the Minister of Plantations, said Sri Lanka is likely to go only with the AstraZeneca vaccines for the second phase of vaccination as the Chinese and Russian vaccines are not ready yet.

“The Chinese vaccine has not submitted the papers relating to phase three trials, said Pathirana.

For the first round of vaccinations, the government has placed an order for 10 million doses of AstraZeneca vaccine from the Serum Institute of India at a cost of $52.5 million and a further 3.5 million doses directly from AstraZeneca Institute of UK under the Covax programme, the spokesman said.

India gifted 500,000 doses of the same vaccine which kicked off Sri Lanka’s vaccine rollout in late January.

Mahinda Rajapaksa

Sri Lankan President Gotabaya Rajapaksa thanked India last month for its generosity after he received 500,000 doses of Covishield vaccine donated by the country under the ‘Neighbourhood First’ policy.

The government will be directed by the best medical advice on when the second dose should be given, Pathirana said, adding that although initially it was believed that the booster jab should be given after four weeks.

Also Read-Imran pitches CPEC to Lanka

Read More-Hungary greenlights China’s Sinopharm vaccine

Previous Story

Imran pitches CPEC to Lanka

Next Story

‘Mint’ Magic in health

Previous Story

Imran pitches CPEC to Lanka

Next Story

‘Mint’ Magic in health

Latest from -Top News

Floods hit growth, but Nepal keeps rating

Nepal maintains its ‘BB-’ sovereign rating for the third consecutive year, supported by strong reserves and concessional borrowing….reports Asian Lite News Desk Nepal has retained its ‘BB-’ sovereign credit rating for the

Pakistan becomes hotbed of infectious diseases

Islamabad’s inability to prevent the rising cases of fatal diseases and provide proper treatment is a matter of international public health security. What could be easily avoided has been allowed to kill

COP31 Faces Fresh Heat Over Fossil Fuel Lobbyists

The presence of fossil fuel-linked representatives in national delegations at COP31 has triggered criticism from climate campaigners and transparency groups…reports Asian Lite News Desk The growing presence of fossil fuel companies at

Bangladesh sees sharp rise in attacks on minorities

Attacks on religious minorities in Bangladesh have risen sharply since the 2024 political upheaval, with rights groups documenting a significant increase in violence during 2026…reports Asian Lite News Desk Attacks on religious
Go toTop